Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
Mirko ScarsiSilvia PiantoniEnrico ColomboPaolo AiróDonata RichiniMarco MicliniValeria BertasiMarta BianchiDamiano BottonePatrizia CivelliMaria-Sofia CotelliEzio DamioliniGloria GalbassiniDiego GattaMaria-Laura GhirardelliRoberto MagriPaola MalamaniMonia MendeniStefano MolinariAndrea MorottiLuisa SaladaMarinella TurlaAngiola VenderAngela TincaniAntonio Luca BrucatoFranco FranceschiniRoberto FurloniLaura AndreoliPublished in: Annals of the rheumatic diseases (2020)
This proof-of-concept study may support the rationale of use of colchicine for the treatment of COVID-19. Efficacy and safety must be determined in controlled clinical trials.